Cargando…

Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawal

INTRODUCTION: Methamphetamine (MA) use disorder is an important public health concern. MA withdrawal is often the first step in ceasing or reducing use. There are no evidence-based withdrawal treatments, and no medication is approved for the treatment of MA withdrawal. Lisdexamfetamine (LDX) dimesil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acheson, Liam S., Ezard, Nadine, Lintzeris, Nicholas, Dunlop, Adrian, Brett, Jonathan, Rodgers, Craig, Gill, Anthony, Christmass, Michael, McKetin, Rebecca, Farrell, Michael, Shoptaw, Steve, Siefried, Krista J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529099/ https://www.ncbi.nlm.nih.gov/pubmed/36190973 http://dx.doi.org/10.1371/journal.pone.0275371

Ejemplares similares

Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta‐analysis of randomised controlled trials
por: Acheson, Liam S., et al.
Publicado: (2022)

Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
por: Siefried, Krista J., et al.
Publicado: (2020)

Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study
por: Ezard, Nadine, et al.
Publicado: (2021)

LiMA: a study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2018)

A clinical research priority setting study for issues related to the use of methamphetamine and emerging drugs of concern in Australia
por: Siefried, Krista J., et al.
Publicado: (2021)

Study protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependence
por: Ezard, Nadine, et al.
Publicado: (2016)

Inpatient GHB withdrawal management in an inner-city hospital in Sydney, Australia: a retrospective medical record review
por: Siefried, Krista J., et al.
Publicado: (2022)

Patterns of smoking and injecting methamphetamine and their association with health and social outcomes
por: McKetin, Rebecca, et al.
Publicado: (2021)

“There’s a big tag on my head”: exploring barriers to treatment seeking with women who use methamphetamine in Sydney, Australia
por: Clifford, Brendan, et al.
Publicado: (2023)

A Web-Based Therapeutic Program (We Can Do This) for Reducing Methamphetamine Use and Increasing Help-Seeking Among Aboriginal and Torres Strait Islander People: Protocol for a Randomized Wait-List Controlled Trial
por: Reilly, Rachel, et al.
Publicado: (2019)

Health and social characteristics of clients reporting amphetamine type substance use at entry to public alcohol and other drug services in New South Wales, Australia, 2016–2019
por: Black, Emma, et al.
Publicado: (2022)

Mandatory treatment for methamphetamine use in Australia
por: Coleman, Mathew, et al.
Publicado: (2021)

Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms
por: Arunogiri, Shalini, et al.
Publicado: (2019)

A prospective study of methamphetamine use as a predictor of high school non-attendance in Cape Town, South Africa
por: Plüddemann, Andreas, et al.
Publicado: (2010)

The Use of Lisdexamfetamine to Treat ADHD in a Patient with Stimulant (Methamphetamine) Use Disorder
por: Levine, J., et al.
Publicado: (2023)

Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?
por: McKetin, Rebecca, et al.
Publicado: (2018)

Understandings, attitudes, practices and responses to GHB overdose among GHB consumers
por: Freestone, Jack, et al.
Publicado: (2023)

Creating a standard inpatient opioid withdrawal protocol
por: Abid, Ariana, et al.
Publicado: (2022)

Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic
por: Dunlop, Adrian, et al.
Publicado: (2020)

Relative Bioavailabilities of Lisdexamfetamine Dimesylate and d-Amphetamine in Healthy Adults in an Open-Label, Randomized, Crossover Study After Mixing Lisdexamfetamine Dimesylate With Food or Drink
por: Ermer, James, et al.
Publicado: (2016)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

Effects of Methamphetamine Withdrawal on the Volume and pH of Stimulated Saliva
por: Zokaee, Haleh, et al.
Publicado: (2022)

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine
por: Pennick, Michael
Publicado: (2010)

Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy
por: Ermer, James C., et al.
Publicado: (2016)

A public health response to the methamphetamine epidemic: the implementation of contingency management to treat methamphetamine dependence
por: Shoptaw, Steven, et al.
Publicado: (2006)

N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial
por: McKetin, Rebecca, et al.
Publicado: (2021)

A Systematic Review of the Safety of Lisdexamfetamine Dimesylate
por: Coghill, David R., et al.
Publicado: (2014)

Update on optimal use of lisdexamfetamine in the treatment of ADHD
por: Madaan, Vishal, et al.
Publicado: (2013)

Potential for Dependence on Lisdexamfetamine - In vivo and In vitro Aspects
por: Yun, Jaesuk, et al.
Publicado: (2017)

Remission of Methamphetamine-Induced Withdrawal Delirium and Craving After Electroconvulsive Therapy
por: Ahmadi, Jamshid, et al.
Publicado: (2015)

Anxiety level and correlates in methamphetamine-dependent patients during acute withdrawal
por: Su, Hang, et al.
Publicado: (2017)

Decreases in Brain Reward Function Reflect Nicotine- and Methamphetamine-Withdrawal Aversion in Rats
por: Miyata, Hisatsugu, et al.
Publicado: (2011)

Impact of Morphine Dependence and Withdrawal on the Reinforcing Effectiveness of Fentanyl, Cocaine, and Methamphetamine in Rats
por: Seaman Jr, Robert W., et al.
Publicado: (2021)

Dynamic immune and exosome transcriptomic responses in patients undergoing psychostimulant methamphetamine withdrawal
por: Wu, Hongjin, et al.
Publicado: (2022)

Lisdexamfetamine prodrug activation by peptidase-mediated hydrolysis in the cytosol of red blood cells
por: Sharman, Johannah, et al.
Publicado: (2014)

Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate
por: Roesch, Benno, et al.
Publicado: (2013)

Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
por: Burleigh, Tara, et al.
Publicado: (2020)

Lisdexamfetamine: Bilateral acute angle closure: case report
Publicado: (2021)

Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
por: Griffiths, Kristi R., et al.
Publicado: (2021)

Quantitative determination of salvinorin A, a natural hallucinogen with abuse liability, in Internet-available Salvia divinorum and endemic species of Salvia in Taiwan
por: Lin, Po-Xiang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mb310ljmsgnn5pu29h737lnp80